Vpriv.com
Visit vpriv.com-
10 months ago
Last scanned
-
14 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Vpriv.com
Visit vpriv.com
About Website
Updated:
VPRIV® (velaglucerase alfa for injection) | Enzyme Replacement Therapy
Type 1 Gaucher Disease (GD1) is a rare, genetic condition that typically runs in the families. This website is a source of information for patients, family and friends.
Network Data
This website is hosted with Amazon.com, Inc., which reserves the following IP addresses for vpriv.com: 99.84.108.10, 99.84.108.28, 99.84.108.49, 99.84.108.58. Moreover, DNS used with this website include ns-1041.awsdns-02.org, ns-1583.awsdns-05.co.uk, ns-396.awsdns-49.com, ns-701.awsdns-23.net. Subnet identifier ranges from 99.84.0.0 to 99.84.255.255. Classless Inter-Domain Routing (CIDR) is 99.84.0.0/16. ARIN net type is Reallocated.
-
10 months ago
Last scanned
-
14 years
Domain Age
-
No data
Daily Visitors
-
No data
Global Rank
Network
ADDRESSING DETAILS
-
Hosting Company
-
IPs
-
DNS
ns-1041.awsdns-02.org
ns-1583.awsdns-05.co.uk
ns-396.awsdns-49.com
ns-701.awsdns-23.net
Whois
OWNERSHIP
-
Created
2009-12-29
-
Expires
2023-12-29
-
Owner
-
Registar
CSC CORPORATE DOMAINS, INC.
-
Owner Emails
Domain & Keywords
The registrar of vpriv.com is CSC CORPORATE DOMAINS, INC. and the name expires on 2023-12-29. According to open source data, you can reach the owner at adminmaster@takeda.com but please make sure you have a good reason for unsolicited messages. Their country of residence is Japan.
- Gaucher disease
- type 1 Gaucher disease
- Rare Disease
- vpriv
- GD1
- vproof
- velaglucerase alfa
- velaglucerase
- Gaucher Disease Caregivers
- Gaucher Disease Patients
Websites similar to vpriv.com
-
asbestos-lungmesothelioma.com-
Global rank
N/A
-
Daily Visitors
N/A
-
-
novartis.com-
Global rank
4K
-
Daily Visitors
16.9K
-
-
novartis.ca-
Global rank
618.2K
-
Daily Visitors
1K
-
-
rarediseaseday.org-
Global rank
29.3K
-
Daily Visitors
1K
-
-
worldpompe.org-
Global rank
N/A
-
Daily Visitors
N/A
-